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Abstract
Objective. To investigate the occurrence of, and risk factors for, pelvic inﬂammatory disease (PID) occurring during the
post-partum year.
Methods. Demographic and clinical data for women who delivered a term infant with 5-minute Apgar score 58 from 1992
through 1999 at a large urban hospital were extracted from an electronic medical record system.
Results. During the study period, 15206 deliveries occurred among 12549 women. PID was diagnosed during the post-
partum year of 148 (1.0%) deliveries. In univariate analysis, young age, black race, and both pre-delivery history and post-
partum diagnosis of chlamydial and gonococcal infection were associated with PID. In multivariate analysis, only young age
and a positive test for gonorrhea before delivery or post-partum were independent predictors of PID.
Conclusions. Pelvic inﬂammatory disease was diagnosed during the post-partum year in 1% of women studied. Young
maternal age was an important demographic risk factor. Further investigation of post-partum STD acquisition and
progression to PID is needed to determine whether women are at increased risk following delivery.
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Introduction
Pelvic inﬂammatory disease (PID), inﬂammation of
the upper female genital tract often associated with
chlamydial or gonococcal infection, is a major
clinical and public health problem. About 1.2 million
episodes of acute PID leading to 130000 hospitaliza-
tions are currently estimated to occur annually in the
United States [1]. The impact of PID exceeds the
burden of acute illness, because PID also causes
serious long-term consequences, including ectopic
pregnancy, infertility, and chronic abdominal or
pelvic pain [2]. Direct medical costs for PID and
its sequelae are estimated to exceed $1.8 billion
annually [1].
The rationale for screening women for chlamydial
and gonococcal infection rests in large part on the
potential of such screening programs to reduce the
incidence of PID [3]. Since the incidence of
chlamydia- or gonorrhea-associated PID depends
both on the probability of acquisition of infection
with these organisms and on the probability of
progression of lower genital tract infection to PID,
factors that increase the probability of either
chlamydial or gonococcal infection will be expected
to lead to greater incidence. Existing screening
recommendations focus on screening women at high
risk for STD acquisition—sexually active young
women, older women with personal risk factors such
as new or multiple sexual partners, and women from
populations with high rates of chlamydial and
gonococcal infection [4]. Economic studies have
suggested that screening for chlamydia is cost-
effective at prevalence of at least 3.1% [5]. However,
if certain populations of women were at higher risk
for development of PID, given lower genital tract
infection, then screening such populations would be
cost-effective at lower prevalence.
Two recent studies have documented substantial
rates of chlamydial and gonococcal infection in post-
partum women, most of whom had negative tests for
these organisms before delivery, raising the question
of whether late pregnancy and the post-partum
period may be a period of increased risk for
acquisition of these STDs [6,7]. Whether chlamydial
or gonococcal infections acquired during the post-
partum period are more likely to progress to PID
than infections acquired at other times is not known.
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existing chlamydial and gonococcal infection is a
well recognized entity [8], and it is plausible that the
cervical, uterine, and immune changes of pregnancy
and delivery, which resolve over six weeks to three
months after delivery [9], could facilitate progres-
sion. In one rigorous study controlling for age,
parous women were at considerably higher risk of
PID than nulliparous women [10], but this study did
not examine time from delivery to PID; to our
knowledge, no epidemiologic studies of PID have
examined the role of recent childbirth in PID. To
explore the epidemiology of PID occurring during
the post-partum year, we used an electronic medical
record system to conduct a cohort study of a large
population of women who delivered an infant in an
urban Midwestern hospital from 1992 through 1999.
Materials and methods
The study was approved by the Institutional Review
Board of Indiana University, Purdue University,
Indianapolis. The study population included all
women who delivered an infant of 37 to 44 weeks
gestational age with a 5-minute Apgar score of 58
from January 1, 1992 through December 31, 1999 at
Wishard Memorial Hospital, a large urban hospital
that serves a diverse but predominantly inner-city
population in Indianapolis.
Clinical data were extracted from the Regenstrief
Medical Records System (RMRS), a comprehensive
electronic medical records system that gathers and
stores data from Wishard Memorial Hospital and its
afﬁliated outpatient sites [11]. Age at delivery,
gravidity, parity, race as recorded by a nurse at the
ﬁrst prenatal visit, mode of delivery, and the results of
all tests for gonorrhea and chlamydia performed
before, during, and after pregnancy were extracted.
Throughout the study period, prenatal chlamydia and
gonorrhea testing was performed routinely at entry to
prenatal care and was repeated as clinically indicated.
Post-partum chlamydia and gonorrhea testing was
performed routinely at the post-partum medical
evaluation (about 55% of women were tested within
12 weeks of delivery in another study in this site) and
in other settings as clinically indicated.
To identify episodes of PID, RMRS inpatient
and outpatient ﬁles were searched for occurrences of
pertinent International Classiﬁcation of Diseases,
Ninth Revision (ICD-9) codes [12] from January 1,
1992 through December 31, 2000, a year after the
last study delivery. To exclude infectious complica-
tions of delivery, only episodes occurring 430 days
after delivery were included. A diagnosis of PID was
deﬁned as the occurrence of an ICD-9 code for acute
adnexitis and oophoritis (614.0); salpingitis and
oophoritis of unspeciﬁed duration (614.2); acute
parametritis and pelvic cellulitis (614.3); pelvic
peritonitis (614.5); unspeciﬁed inﬂammatory disease
of female pelvic organs and tissues, which includes
the diagnosis ‘pelvic inﬂammatory disease’ (614.9);
gonococcal perihepatitis/Fitz-Hugh–Curtis syn-
drome (098.86); chlamydial perihepatitis (099.56);
or episodes coded as either abdominal pain (625.9)
or pelvic pain (789.0) occurring within two days of a
positive test for gonorrhea or chlamydia.
For each delivery, ICD-9 codes that occurred
from 31 to 365 days after delivery were included.
However, if the woman became pregnant again
during the post-partum year, her observations were
censored at the estimated date of conception, which
was determined by subtracting the gestational age at
subsequent delivery from the date of that delivery.
Also, to attempt to exclude person-time for women
who did not obtain follow-up care at RMRS sites,
observations for women who had no visits recorded
in the RMRS after the post-partum year were
censored on the date of their last RMRS entry
during the post-partum year.
Written medical records of all women with more
than one diagnosis of PID were reviewed to
determine whether the multiple codes represented
multiple episodes of illness; dates that represented
follow-up examinations for earlier episodes were not
included. These records as well as records of all
women hospitalized within seven days before or after
the date of the ICD-9 code, of all women who were
included as PID cases on the basis of ICD-9 codes
625.9 or 789.0, and of additional women chosen at
random were also reviewed to validate the diagnostic
coding.
Statistical analyses were conducted with SAS
version 8.2 (SAS Institute, Cary, NC) and S-Plus
version 6.1 (Seattle, WA). Race was dichotomized as
black versus non-black, based on previous work in
this Indianapolis population that showed higher
prevalence of chlamydial and gonococcal infection
among women identiﬁed as black and uniformly
lower prevalence within non-black groups. Parity was
dichotomized as 0 versus 51, and gravidity as 1
versus 52. Post-partum and pre-delivery (including
both pre-pregnancy and prenatal) chlamydial and
gonococcal infection status were classiﬁed as ‘ever
positive’, ‘never positive’, or ‘never tested’ for each
time period. For women diagnosed with post-partum
PID, only tests for chlamydia and gonorrhea that
were performed on or before the date of PID
diagnosis were included. p-Values for measures of
association in a bivariate analysis of each predictor
variable and post-partum PID were obtained using
Generalized Estimating Equations to adjust for cor-
related observations due to multiple deliveries
in some women [13]; predictor variables with
192 B. E. Mahon et al.p-values50.3 were retained for further investigation
in a multivariate survival model.
Survival analysis of time to PID after delivery
was conducted using an Andersen–Gill model,
which adjusts for multiple events occurring in the
same subject [14]. This model was developed to
examine the effects of chlamydial and gonococcal
infection on the time to occurrence of PID, after
adjustment for relevant covariates. Infection status
for both organisms, pre-delivery and post-partum,
were ﬁxed in the model. Age, gravidity, parity, mode
of delivery, and race were also included in an initial
model. Records with missing data on variables
included in the model and records for women whose
observation time was censored at 430 days post-
partum were excluded. Stepwise backward selection
of variables was used to obtain the ﬁnal model.
Results
During the study period, 15 206 eligible deliveries
occurred among 12 549 women. Table I summarizes
data on these deliveries. Chlamydial and gonococcal
infection were common in this population, with at
least one positive pre-delivery (before or during
pregnancy) test for chlamydia for 4028 (26.5%)
deliveries and for gonorrhea for 2244 (14.8%)
deliveries and with lower but still substantial
numbers of positive tests during the post-partum
year. Women who were ‘never positive’ for these
STDs were similar demographically and in rates of
post-partum PID to women who were ‘never tested’,
so these categories were combined for further
analysis.
A full year of observation was available for 10 906
(71.7%) deliveries; observation was censored be-
tween 30 and 364 days for 3316 (21.8%).
Observation was censored 430 days after delivery
for 984 (6.5%) deliveries; since our deﬁnition of PID
excluded episodes occurring this soon after delivery,
these deliveries could not have contributed PID
episodes and were excluded from PID-related
analyses. Deliveries with post-partum observation
censored 430 days after delivery were somewhat
more likely to have been to non-black women, to
multiparous women, and to women without a
previous positive gonorrhea or chlamydia test.
All of the PID-deﬁning ICD-9 codes were found
in the RMRS. Within the post-partum year for study
women, ICD-9 code 614.9 (includes ‘pelvic inﬂam-
matory disease’) occurred 129 times, and 614.0
(acute adnexitis and oophoritis) and 614.2 (salpingi-
tis and oophoritis of unspeciﬁed duration) occurred
three times each. Code 625.9 (abdominal pain)
occurred within two days of a positive test for
gonorrhea or chlamydia 11 times, and 789.0 (pelvic
pain) ﬁve times; of these episodes, half were
associated with gonorrhea and half with chlamydia.
Thus, a total of 151 episodes met the deﬁnition of a
diagnosis of PID. One woman had PID following
two different deliveries, and three women had two
separate episodes of PID in the year following a
delivery. Thus, PID was diagnosed during the post-
partum year of 148 (1.0%) deliveries. Figure 1
shows the incidence rate by post-partum month of
these illnesses.
In bivariate analysis, young age was strongly
associated with post-partum PID; the odds of
post-partum PID decreased by 6% for each addi-
tional year of age (p50.0001). Table II shows the
association of other demographic and clinical vari-
ables with post-partum PID; black race and both
pre-delivery history and post-partum diagnosis of
chlamydial and gonococcal infection were statistically
signiﬁcantly associated with PID. In multivariate
Table I. Characteristics of deliveries of infants at gestational age 37
to 44 weeks with a 5-minute Apgar score of 58 from January 1,
1992 through December 31, 1999 at Wishard Memorial Hospital,
Indianapolis, IN.
Characteristics of deliveries
Total number of deliveries 15 206
Number of mother’s deliveries
during study period, n (%)
1 10 276 (67.6)
2 3846 (25.3)
53 1084 (7.1)
Mother’s age in years at delivery,
median (range)
22 (12–47)
Race, n (%)
Black 8439 (55.5)
Non-black 6726 (44.2)
Not recorded 41 (0.3)
Gravidity, recorded at onset
of prenatal care, n (%)
1 4030 (26.5)
52 9111 (59.9)
Not recorded 2065 (13.6)
Parity, recorded at onset
of prenatal care, n (%)
0 4773 (31.4)
51 7864 (51.7)
Not recorded 2569 (16.9)
Mode of delivery, n (%)
Caesarean 2176 (14.3)
Vaginal 12 995 (85.5)
Not recorded 35 (0.2)
Positive STD test before or during
pregnancy, n (%)
Chlamydia 4028 (26.5)
Gonorrhea 2244 (14.8)
Positive STD test during years
post-partum*, n (%)
Chlamydia 700 (4.6)
Gonorrhea 337 (2.2)
*For women with PID, only tests that preceded or coincided with
the PID episode were included.
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gonorrhea either before delivery or post-partum were
independent predictors of time to PID, but black race
and positive tests for chlamydia were not. The ﬁnal
model is shown in Table III.
In all, 31 women were hospitalized during the
post-partum illness episode. Review of these medical
records showed that 22 (71%) women had a
discharge diagnosis of PID; two who were admitted
with diagnoses of PID had a discharge diagnosis of
pyelonephritis; one each had appendicitis, chole-
lithiasis, gastroenteritis, and ureteral calculus; and
records for three women were not available. An
additional 53 women treated as outpatients were
selected for record review; records of 43 (81%) were
available. Many records were missing key clinical
information, such as white blood cell count, used in
the CDC deﬁnition of PID, but uterine, adnexal,
or cervical motion tenderness was documented in
36 (84%) of these records, and, among the other
7 records, 3 documented both abdominal pain
and concurrent infection with chlamydia alone or
together with gonorrhea.
Discussion
This study shows that, in this urban Midwestern site
with a high rate of prenatal STDs, PID was diagnosed
during the year following 1% of deliveries. To our
knowledge, this is the ﬁrst epidemiologic study of PID
to focus on post-partum women beyond the immedi-
ate post-partum days and weeks. Although an annual
rate of PID of 1% may seem high, it is difﬁcult for two
reasons to compare this rate to that in other popula-
tions. First, methodological issues and uncertainty in
the clinical diagnosis of PID have produced a wide
range of estimated PID frequency in the United States
[2]. Second, our study examined only post-partum
women, therefore we do not know how the PID rate
we observed would have compared to the rate among
an otherwise-similar group of women who had not
delivered in the previous year. We believe that the
value of this study lies in calling attention to the
question of whether STD acquisition and progression
during pregnancy and the post-partum period may
increase the risk of PID after childbirth. This question
should be addressed in prospective studies.
Consistent with studies of other chlamydia- and
gonorrhea-related outcomes, our multivariate model
of time to PID showed that young age was a strong
independent risk factor for PID during the year after
delivery [15–17]. A positive test for gonorrhea, either
post-partum or before or during pregnancy was also
independently associated with PID during the post-
partum year. Although we do not have data to
document that pre-delivery infections were treated,
clinical practice is to treat these infections at the time
of diagnosis and to conﬁrm that treatment has been
completed at subsequent prenatal visits and at
delivery. Therefore, our ﬁnding of an association of
post-partum PID with pre-delivery gonococcal in-
fection is consistent with other studies that have
shown that women with STDs often become re-
infected after treatment [18–23]. The ﬁnding that
positive chlamydia tests were not independently
associated with PID may reﬂect the fact that
Figure 1. Incidence rate (bar) and number (above bar) by post-partum month of episodes of PID diagnosed during the post-partum year
(excluding the ﬁrst post-partum month).
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than gonorrhea, and therefore may be less likely to
result in an acute illness recognized as PID.
This study is limited by its reliance on existing
medical records and ICD-9 codes to deﬁne episodes
of PID. Because of this method of data collection, we
were unable to use strict clinical and laboratory
criteria to deﬁne PID, as has been proposed to
improve the speciﬁcity of the diagnosis of PID [4,24].
However, review of the complete written medical
records of women who were hospitalized for their
illness showed that 71% had a discharge diagnosis of
PID and that, among women treated as outpatients,
the vast majority had symptoms consistent with PID,
including cervical, uterine, or adnexal tenderness in
84%, consistent with CDC’s recommendation for
minimum criteria for treatment for PID [4]. Even if
some of the illnesses coded as PID would not have
met a strict clinical case deﬁnition, it seems likely that
many of them would have.
Several aspects of the study design may have
tended to decrease the observed incidence of PID.
First, deliveries in which the infant was born
prematurely or with a 5-minute Apgar score 58
were excluded, because of the complex interaction of
existing maternal infections with these outcomes.
Although few deliveries were excluded for these
reasons, it is plausible that these mothers could have
been at higher risk for subsequent PID. Similarly, one
could argue that censoring women who did not
return for follow-up at RMRS sites, although prudent
to ensure that women were under observation, may
have excluded women who were less reliable users of
healthcare and perhaps were at higher risk for PID.
Few studies have examined the role of
childbearing—pregnancy, delivery, and the post-
partum period—in STD acquisition or in the
development of PID. However, many aspects of
this period—decreased coital activity or abstinence
during late pregnancy, the possibility of increased
extra-dyadic sexual relationships by male partners,
frequent early resumption of coitus during the
post-partum period, and possible increased biolo-
gical susceptibility due to the physical changes to
the genital tract associated with delivery—suggest
that it could represent a time of increased risk.
Our previous study in this setting showed an unex-
pectedly high rate of new chlamydial and gono-
coccal infections diagnosed during the 12 weeks
post-partum [7], as did a study of post-partum
adolescents in Connecticut [6]. The high absolute
Table II. Association of demographic and clinical characteristics
with PID diagnosed during the post-partum year. Observations
with missing values are excluded.
Characteristics
PID diagnoses
per 1000
deliveries RR p-value*
Race
Black 13.0 2.19 50.0001
Non-black 5.9 Ref
Gravidity
1 9.7 1.05 0.97
52 10.2 Ref
Parity
0 10.1 0.97 0.82
51 9.8 Ref
Mode of delivery
Caesarean 9.6 0.96 0.79
Vaginal 10.0 Ref
Pre-delivery
chlamydia
Yes 17.4 2.40 50.0001
No 7.2 Ref
Pre-delivery
gonorrhea
Yes 26.3 3.70 50.0001
No 7.1 Ref
Post-partum
chlamydia
Yes 25.7 2.81 0.002
No 9.2 Ref
Post-partum
gonorrhea
Yes 97.9 12.34 50.0001
No 7.9 Ref
*p-Values were obtained using generalized estimating equations to
adjust for correlated observations due to multiple deliveries in
some women. RR, risk ratio; Ref, reference.
Table III. Survival analysis of time to PID after delivery, examining the effects of chlamydial and gonococcal infection on the time to
occurrence of PID after adjustment for covariates (n=14 156*).
Variable Hazard Ratio 95% Confidence Interval p-Value
Age
y 0.954 0.917, 0.991 0.02
Predelivery C. trachomatis
z 1.375 0.919, 2.058 0.12
Predelivery N. gonorrhoeae
z 2.028 1.321, 3.113 0.001
Post-partum C. trachomatis
x 1.132 0.574, 2.232 0.72
Post-partum N. gonorrhoeae
x 8.525 4.902, 14.828 50.0001
C. trachomatis, Chlamydia trachomatis; N. gonorrhoeae, Neisseria gonorrhoeae. *Records with missing data on variables included in the
model and records censored at 430 days post-partum were excluded;
yHazard ratio for each additional year of age;
zDefined as ever positive
versus never positive/not tested for the pre-pregnancy and prenatal period;
xDefined as ever positive versus never positive/not tested during
the post-partum period. For women with PID, only tests that preceded or coincided with the PID episode were included.
Post-partum PID 195rate of PID that we found is consistent with, but
without a non-post-partum comparison group does
not speciﬁcally support, the hypothesis that risk for
PID is increased after delivery. Future research to
explore the role of pregnancy, childbirth, and the
post-partum period in STD acquisition and in
progression to PID is needed. If increased risk is
conﬁrmed, then it will be important to investigate
biological and behavioral reasons and to explore
prevention strategies.
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